135 related articles for article (PubMed ID: 9763090)
1. Evaluation of staging lymphadenectomy in prostate cancer.
El-Galley RE; Keane TE; Petros JA; Sanders WH; Clarke HS; Cotsonis GA; Graham SD
Urology; 1998 Oct; 52(4):663-7. PubMed ID: 9763090
[TBL] [Abstract][Full Text] [Related]
2. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
3. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
4. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
5. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
[TBL] [Abstract][Full Text] [Related]
6. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
7. Indications for pelvic lymphadenectomy in prostate cancer.
Link RE; Morton RA
Urol Clin North Am; 2001 Aug; 28(3):491-8. PubMed ID: 11590808
[TBL] [Abstract][Full Text] [Related]
8. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.
Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE
Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577
[TBL] [Abstract][Full Text] [Related]
9. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
[TBL] [Abstract][Full Text] [Related]
10. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
11. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
12. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
[TBL] [Abstract][Full Text] [Related]
13. Nondissection of pelvic lymph nodes does not influence the results of perineal radical prostatectomy in selected patients.
Salomon L; Hoznek A; Lefrère-Belda MA; Bellot J; Chopin DK; Abbou CC
Eur Urol; 2000 Mar; 37(3):297-300. PubMed ID: 10720855
[TBL] [Abstract][Full Text] [Related]
14. Implications of greater short-term PSA recurrence with laparoscopic as compared to retropubic radical prostatectomy for Japanese clinically localized prostate carcinomas.
Akita H; Okamura T; Ando R; Nagata D; Naruyama H; Yamada Y; Naiki T; Yasui T; Tozawa K; Kohri K
Asian Pac J Cancer Prev; 2011; 12(11):2959-61. PubMed ID: 22393971
[TBL] [Abstract][Full Text] [Related]
15. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
[TBL] [Abstract][Full Text] [Related]
16. [Is there a place for radical prostatectomy without lymphadenectomy?].
Isorna S; Parra RO; García-Pérez M; Gómez M; Valero Puerta JA
Arch Esp Urol; 1995 Jun; 48(5):453-7. PubMed ID: 7639567
[TBL] [Abstract][Full Text] [Related]
17. Open pelvic lymph node dissection for prostate cancer: a reassessment.
Campbell SC; Klein EA; Levin HS; Piedmonte MR
Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933
[TBL] [Abstract][Full Text] [Related]
18. PSA density versus risk stratification for lymphadenectomy-making decision in patients with prostate cancer undergoing radical prostatectomy.
Sfoungaristos S; Perimenis P
Int Urol Nephrol; 2011 Dec; 43(4):1073-9. PubMed ID: 21437595
[TBL] [Abstract][Full Text] [Related]
19. Staging laparoscopic pelvic lymphadenectomy in prostate cancer.
Shackley DC; Irving SO; Brough WA; O'Reilly PH
BJU Int; 1999 Feb; 83(3):260-4. PubMed ID: 10233490
[TBL] [Abstract][Full Text] [Related]
20. [Radical perineal prostatectomy without lymphadenectomy. Patients with cT1 + 2, G1 +2, PSA < or = 10 ng/ml prostate carcinoma].
Jakse G; Brehmer B; Wolff JM; Aretz R; Handt S
Urologe A; 1999 Mar; 38(2):143-9. PubMed ID: 10231935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]